BRIDGEWAY CAPITAL MANAGEMENT, LLC - MENLO THERAPEUTICS INC ownership

MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 53 filers reported holding MENLO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of MENLO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$283,000
-55.0%
105,500
-22.1%
0.01%
-25.0%
Q4 2019$629,000
+5.5%
135,500
+1.8%
0.01%0.0%
Q3 2019$596,000
-24.5%
133,100
+1.1%
0.01%
-20.0%
Q2 2019$789,000
-23.7%
131,7000.0%0.01%
-23.1%
Q1 2019$1,034,000
+100.8%
131,700
+5.4%
0.01%
+85.7%
Q4 2018$515,000
-58.1%
124,9000.0%0.01%
-41.7%
Q3 2018$1,230,000124,9000.01%
Other shareholders
MENLO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
venBio Partners L.P. 1,461,552$11,868,00012.24%
Vivo Capital, LLC 4,011,236$32,571,0004.20%
DAFNA Capital Management LLC 312,000$2,533,0001.19%
Novo Holdings A/S 1,436,313$11,663,0001.17%
Perceptive Advisors 1,241,287$10,079,0000.26%
Rock Springs Capital Management LP 330,000$2,680,0000.10%
Baker Brothers Advisors 700,000$5,684,0000.04%
Schonfeld Strategic Advisors LLC 50,000$406,0000.02%
A.R.T. Advisors, LLC 31,703$257,0000.01%
JANUS HENDERSON GROUP PLC 2,036,111$16,533,0000.01%
View complete list of MENLO THERAPEUTICS INC shareholders